Primary Site >> Stomach Cancer

Gene >> CREM

  • 2017
Ref: Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
PMID: 27870079
Ref: Using Performance-Based Risk-Sharing Arrangements to Address Uncertainty in Indication-Based Pricing.
PMID: 28944729